Abstract
1. Insulin concentration changes in pancreatico-duodenal venous plasma were studied in anaesthetized dogs injected with caerulein.
2. Rises in insulin concentration were elicited by rapid intravenous injection of caerulein, as well as by intravenous infusion. Threshold doses were 10 ng/kg and 0·5-1 (ng/kg)/min respectively.
3. At the highest dose used (500 ng/kg by rapid intravenous injection and (25 ng/kg)/min by intravenous infusion) the increase in immuno-reactive insulin release was approximately 7 to 9 times the base levels.
4. Adrenalectomy potentiated the effects of intravenous infusion of caerulein.
5. On a molar basis, caerulein was 2-3 times as active as pancreozymin.
6. It is concluded that caerulein is a potent stimulant of pancreatic islets in the dog and that it may be considered as a model peptide, capable of being substituted for pancreozymin in any experiment.
7. The mechanism of the insulin stimulating effect of caerulein is discussed. The possibility of a direct “β-cytotropic” effect of the peptide is suggested.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anastasi A., Erspamer V., Endean R. Isolation and amino acid sequence of caerulein, the active decapeptide of the skin of hyla caerulea. Arch Biochem Biophys. 1968 Apr;125(1):57–68. doi: 10.1016/0003-9861(68)90638-3. [DOI] [PubMed] [Google Scholar]
- Bertaccini G., De Caro G., Endean R., Erspamer V., Impicciatore M. The action of caerulein on pancreatic secretion of the dog and biliary secretion of the dog and the rat. Br J Pharmacol. 1969 Sep;37(1):185–197. doi: 10.1111/j.1476-5381.1969.tb09537.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bertaccini G., De Caro G., Endean R., Erspamer V., Impicciatore M. The actions of caerulein on the smooth muscle of the gastrointestinal tract and the gall bladder. Br J Pharmacol. 1968 Oct;34(2):291–310. doi: 10.1111/j.1476-5381.1968.tb07052.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Buchanan K. D., Vance J. E., Morgan A., Williams R. H. Effect of pancreozymin on insulin and glucagon levels in blood and bile. Am J Physiol. 1968 Dec;215(6):1293–1298. doi: 10.1152/ajplegacy.1968.215.6.1293. [DOI] [PubMed] [Google Scholar]
- Curry D. L., Bennett L. L., Grodsky G. M. Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology. 1968 Sep;83(3):572–584. doi: 10.1210/endo-83-3-572. [DOI] [PubMed] [Google Scholar]
- Dorigotti L., Glässer A. H. Comparative effects of caerulein, pancreozymin and secretin on pancreatic blood flow. Experientia. 1968 Aug 15;24(8):806–807. doi: 10.1007/BF02144881. [DOI] [PubMed] [Google Scholar]
- FROESCH E. R., RENOLD A. E. Specific enzymatic determination of glucose in blood and urine using glucose oxidase. Diabetes. 1956 Jan-Feb;5(1):1–6. doi: 10.2337/diab.5.1.1. [DOI] [PubMed] [Google Scholar]
- HALES C. N., RANDLE P. J. Immunoassay of insulin with insulin-antibody precipitate. Biochem J. 1963 Jul;88:137–146. doi: 10.1042/bj0880137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kanazawa Y., Kuzuya T., Ide T. Insulin output via the pancreatic vein and plasma insulin response to glucose in dogs. Am J Physiol. 1968 Sep;215(3):620–626. doi: 10.1152/ajplegacy.1968.215.3.620. [DOI] [PubMed] [Google Scholar]
- Meade R. C., Kneubuhler H. A., Schulte W. J., Barboriak J. J. Stimulation of insulin secretion by pancreozymin. Diabetes. 1967 Mar;16(3):141–144. doi: 10.2337/diab.16.3.141. [DOI] [PubMed] [Google Scholar]
- Unger R. H., Ketterer H., Dupré J., Eisentraut A. M. The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs. J Clin Invest. 1967 Apr;46(4):630–645. doi: 10.1172/JCI105565. [DOI] [PMC free article] [PubMed] [Google Scholar]